ABP-102
Product Specifications
Target
Integrin, HER
Related Pathways
Angiogenesis, Cytoskeletal Signaling, JAK/STAT signaling, Tyrosine Kinase/Adaptors
Bioactivity
ABP-102 (CT P72) is a tetravalent IgG1-[L]-scFv bispecific t-cell adduct (BiTE) that acts as a CD3 modulator and selective HER2 modulator for the selective targeting of HER2 overexpressing tumors. ABP-102 showed cytotoxicity in HER2-overexpressing models of breast and gastric cancers, while significantly decreasing activity against HER2 low level cells, twice as effective as rununmotamab.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LS054431-100ug 100 µg
DNAJC10 (NM_018981) Human Over-expression Lysate
Sign In for Pricing
View Details MBS390004-01 0.5 mg
FITC-conjugated Goat Anti-Human ApolipoproteinB-100
Sign In for Pricing
View Details